Vanguard Amendment Shows 0% Stake in Astera Labs
Astera Labs Inc Schedule 13G/A amendment: The Vanguard Group reports zero beneficial ownership of Astera Labs common stock following an internal realignment that disaggregated certain subsidiaries' holdings, in accordance with SEC Release No. 34-39538.
Rhea-AI Filing Summary
Astera Labs Inc Schedule 13G/A amendment: The Vanguard Group reports zero beneficial ownership of Astera Labs common stock following an internal realignment that disaggregated certain subsidiaries' holdings, in accordance with SEC Release No. 34-39538.
The filing states Vanguard’s subsidiaries will report beneficial ownership separately and that Vanguard no longer is deemed to beneficially own the shares previously reported by those units.
Positive
- None.
Negative
- None.
Insights
Vanguard disaggregated holdings; reporting entity shows no ownership.
The amendment records 0 shares and 0% ownership, citing an internal realignment and reliance on SEC Release No. 34-39538. This reflects a reporting change where subsidiaries now file separately rather than a market trade.
Cash‑flow treatment and any subsidiary-level holdings are not included in this amendment; subsequent filings by the relevant Vanguard subsidiaries would show actual positions.
Amendment clarifies reporting structure, not a transactional disposition.
The statement explains an internal realignment effective January 12, 2026
and reliance on the specified SEC release to disaggregate beneficial ownership. The practical effect is administrative: ownership will be reported by separate Vanguard entities going forward.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does The Vanguard Group report for Astera Labs (ALAB)?
Why does Vanguard say it has zero ownership of ALAB?
Who signed the Schedule 13G/A for Vanguard?
Will Vanguard subsidiaries now file separate ownership reports for ALAB?
AI-generated analysis. How Rhea-AI works. Not financial advice.